Neurocrine Bioscience buy Truist Financial Co.
Start price
30.10.25
/
50%
€119.35
Target price
30.10.26
€148.09
Performance (%)
-6.20%
Price
11.03.26
€111.95
Summary
This prediction is currently active. With a performance of -6.20%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. This prediction currently runs until 30.10.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -0.885% | -0.885% |
| iShares Core DAX® | -2,53 % | -5,19 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % |
| iShares S&P 500 | -0,80 % | 0,16 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its "buy" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $172.00 price target on the stock, up previously from $165.00.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
17.02.26
17.02.26
€118.20
17.02.27
17.02.27
3.80%
11.03.26
11.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.75
08.01.26
08.01.26
€144.77
08.01.27
08.01.27
-4.11%
11.03.26
11.03.26